Comparison Entero Therapeutics, Inc. Common Stock (ENTO) with Competitors
Entero Therapeutics, Inc. Common Stock (ENTO) industry is Biotechnology.
Debt-to-Equity
ENTO2.51%
Industry28.27%
Upside-91.12%
Free Cash Flow Yield
ENTO-44.58%
Industry-1.75%
Upside-42.83%
P/E
ENTO-2.89
Industry-20.52
Upside+1762.35%
P/B
ENTO0.15
Industry5.15
Upside-97.03%